Study explains why infants contract so many common respiratory ailments

DN Bureau

Researchers from Columbia University have discovered a unique cluster of immune cells that are only seen in newborns that enable them to deal with novel pathogens and explain why infants contract so many common respiratory ailments. Read further on Dynamite News:

Representational Image
Representational Image


New York: Researchers from Columbia University have discovered a unique cluster of immune cells that are only seen in newborns that enable them to deal with novel pathogens and explain why infants contract so many common respiratory ailments.

“We know little about how the immune system develops throughout life, and most of what we know about immune system development in children comes from animal studies,” says Donna Farber, PhD, an expert in immune system development at Columbia University Vagelos College of Physicians and Surgeons who led the research. “But mice develop much more quickly than humans and their immune systems are a bit different than ours.”

Farber's team was able to identify features of immune system development that set babies apart from adults using a wealth of tissue samples from dead paediatric organ donors.

According to a study that was published in the journal Immunity, memory T cells, which are generated after a person first comes into contact with a virus, accumulate quickly in the lungs and intestines until the age of three and more gradually in the blood and lymph tissues. When a virus is encountered again, older children and adults can mount a quick and focused immune response thanks to these cells.

Also Read | Maternal depression may affect child's immune and psychological health

“We found that memory T cells in young children are not functionally mature and only begin to have the capacity for protective immunity at around ages 4 to 6 years,” Farber says. “This explains why babies and young children are more vulnerable to recurrent respiratory infections and other infectious diseases compared with adults.”

The findings also may explain why introducing foods to children during the first year of life could prevent severe food allergies. “Early memory T cells are more tolerant than mature memory cells, so they’re not going to create an immune response against new foods,” Farber said.

‘Secret weapon’ protects babies from new pathogens. But while babies are highly susceptible to recurrent infections, a second study, published in Nature Immunology, found that babies have a unique way of coping with new pathogens. The researchers found clusters of antibody-producing B cells surrounded by T cells in the infants’ lungs. This bronchus-associated lymphoid tissue, or BALT, is formed between 6 and 12 months of age and disappears after age 3. 

“BALT enables the lung to make antibodies to respiratory pathogens well before T cell memory has developed but fall apart in later childhood when they are no longer needed,” says Farber. “This mechanism helps young children respond to the many different respiratory pathogens they encounter early in life.”

Also Read | Study finds link between children sleep problems, psychosis in young adults

It also may explain why young kids are more resilient to new respiratory infections compared to adults—including SARS-CoV-2. “With SARS-CoV-2, a virus no one had ever encountered before, we saw that people in their 50s and 60s were very susceptible to severe COVID, but most kids exposed to SARS-CoV-2 were fine, and many didn’t even have symptoms,” Farber says. “That told us that the babies and young children must have some adaptations to respond to new pathogens that adults don’t have.”

BALT also may be a reason why some children develop chronic asthma and allergies. “It’s possible that these diseases may be caused in part by the abnormal persistence of BALT well into childhood, which could trigger an overreaction to certain antigens,” said Farber.

Farber adds that the study may provide clues about why early trials of intranasal COVID vaccines have not shown promise in adults, whereas intranasal influenza vaccine tends to work better in children. “It could be that this type of vaccine works better in children because they have BALT structures that can initiate new antibodies in the lungs.”

“BALT provides some protection but clearly does not protect young children from everything,” Farber continues. “We have to remember that before vaccines, a third of children died of infectious diseases during infancy. So childhood vaccines are really important for protecting us.” (ANI)










Related Stories